Skip to main content

Table 1 General characteristics of guidelines

From: Just give the contrast? Appraisal of guidelines on intravenous iodinated contrast media use in patients with kidney disease

Guideline

Reference

Organization(s)

Year

Region

STAR score

ESUR_2018

[33]

European Society of Urogenital Radiology

2018

Europe

61.5

RANZCR_2018

[34]

Royal Australian and New Zealand College of Radiologists

2018

Australian and New Zealand

58.7

JRS-JCS-JSN_2018

[35]

Japanese Society of Nephrology, Japan Radiological Society, Japanese Circulation Society

2018

Japan

57.5

UCSF-USC_2020

[36]

University of California San Francisco, University of Southern California

2020

USA

28.5

ACR-NKF_2021

[37]

American College of Radiology, National Kidney Foundation

2021

USA

38.0

CSR_2021

[38]

Chinese Society of Radiology

2021

China

37.3

CSCP-CPA-CSN_2022

[39]

Chinese Society of Clinical Pharmacy, Chinese Pharmaceutical Association, Chinese Society of Nephrology

2022

China

47.5

SIRM-SIN-AIOM_2022

[40]

Italian College of Radiology, Italian College of Nephrology, Italian Association of Medical Oncology

2022

Italia

39.4

CAR_2022

[41]

Canadian Association of Radiologists

2022

Canada

46.3

ACR_2023

[42]

American College of Radiology

2023

USA

45.6

  1. ACR American College of Radiology, ACR-NKF American College of Radiology, and National Kidney Foundation,CAR Canadian Association of Radiologists, CSCP-CPA-CSN Chinese Society of Clinical Pharmacy, Chinese Pharmaceutical Association, and Chinese Society of Nephrology, CSR Chinese Society of Radiology, ESUR European Society of Urogenital Radiology, JRS-JCS-JSN Japan Radiological Society, Japanese Circulation Society, and Japanese Society of Nephrology, RANZCR Royal Australian and New Zealand College of Radiologists, SIRM- SIN-AIOM Italian College of Radiology, Italian College of Nephrology, and Italian Association of Medical Oncology, UCSF-USC University of California San Francisco, and University of Southern California